Welcome to the Pacific Edge Investor Centre. Here you will find useful information about being a shareholder of our company.
See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up on our share price.
Pacific Edge is a publicy listed company on the NZX: listed as PEB.
- Value $00,000.000
- Volume 00,000
- Capitalisation $000,000
- Open $0.000
- Close $0.000
- High $0.000
- Low $0.000
Data up to date as of 00-00-0000 00:00
Pacific Edge Half Year Results to be Announced 29 November 2017
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB), advises the release of its interim results for the six months ended 30 September 2017, on Wednesday 29 November 2017. [read more]
Pacific Edge Named 20th in Deloitte Fast50
The team at Dunedin cancer diagnostics company, Pacific Edge, is celebrating today after being named the 20th fastest growing company in the Deloitte Fast50 Awards, coming in with 324% growth in revenue over three years. [read more]
Pacific Edge Completes Shortfall Bookbuild and $21.3 Million Capital Raising
Pacific Edge Limited (NZX: PEB) (Pacific Edge) advises that it has completed the shortfall bookbuild component of its $21.3 million capital raise announced on 11 October 2017 (Offer), with support from both institutional and other eligible shareholders. All of the shares available under the Offer have now been taken up. [read more]
Reports and Presentations
For further investor information on Pacific Edge our recent annual reports, investor presentations and investment research reports are available for download below
FY17 Full Year Results Conference Call Audio Commentary[5.8 MB]
FY17 Full Year Results Presentation[3.1 MB]